Cost-effectiveness of Dabigatran Compared With Rivaroxaban for Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in China

Citation
Dong SJ, Wu B, Zhai SD, et al. Clin Ther 2020;42(1):144-156.e1.